2026-01-29 - Analysis Report
**Market Analysis of Intuitive Surgical (ISRG)**

### Company Overview
Intuitive Surgical is a medical device company specializing in robotic surgical systems.

### Return Rate Comparison

* Cumulative return of ISRG: 200.33%
* Cumulative return of S&P 500 (VOO): 128.51%
* Divergence: 71.80
* Relative divergence: 46.70%

### Alpha, Beta Analysis

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|-----|------|------|-------|------|-------|
| 2016-2018 | 66.0% | 21.8% | 57.0% | 1.2 | 56.9B |
| 2017-2019 | 73.0% | 21.8% | 48.0% | 1.4 | 70.2B |
| 2018-2020 | 54.0% | 39.7% | 30.0% | 1.2 | 97.2B |
| 2019-2021 | 89.0% | 39.7% | 25.0% | 1.2 | 128.0B |
| 2020-2022 | 13.0% | 45.7% | 8.0% | 1.2 | 94.5B |
| 2021-2023 | 12.0% | 45.7% | -6.0% | 1.4 | 120.2B |
| 2022-2024 | 107.0% | 36.7% | 78.0% | 1.3 | 186.0B |
| 2023-2025 | 152.0% | 27.8% | 77.0% | 1.2 | 201.8B |

### Recent Stock Price Fluctuations

* Close: $525.04
* Last-market: $521.8 (change: -0.62)
* 5-day SMA: $525.47
* 20-day SMA: $555.58
* 60-day SMA: $559.25

### RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.70
* RSI: 9.64
* PPO: -0.87
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -4.10 (-) (worsening)
* 7-day Rank change: 45 (+) (rank up)
* 7-day Dynamic Expected Return change: 65.80 (+) (improving)
* Expected Return (%): 75.10%

### Recent News & Significant Events

* [2026-01-23] Why Intuitive Surgical's Lackluster 2026 Guidance Isn't All Doom - Investor's Business Daily
* [2026-01-07] Is ISRG Stock Still A Buy At $600? - Forbes
* [2026-01-03] This Robotic Surgery Pioneer Could Be Worth $1 Million for Long-Term Holders - The Motley Fool
* [2026-01-27] Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures - TechStockÂ²
* [2026-01-28] Is It Time To Reassess Intuitive Surgical (ISRG) After Recent Share Price Weakness? - Yahoo Finance UK
* [2026-01-23] ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines - Zacks Investment Research

### Analyst Opinions

Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.97 (~Buy)
* Opinions: 31
* Target Price (avg/high/low): 611.82 / 750.00 / 378.00

### Recent Earnings Analysis

| Date | EPS | Revenue |
|-----|----|----------|
| 2025-10-22 | 1.98 | 2.51 B$ (repeated 2024-10-22) |
| 2025-07-23 | 1.84 | 2.44 B$ |
| 2025-04-23 | 1.95 | 2.25 B$ |
| 2024-10-18 | 1.59 | 2.04 B$ |

### Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | 2.51B | 66.36% |
| 2025-06-30 | 2.44B | 66.31% |
| 2025-03-31 | 2.25B | 64.69% |
| 2024-12-31 | 2.41B | 68.04% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | 16.93B | 4.16% |
| 2025-06-30 | 17.85B | 3.69% |
| 2025-03-31 | 17.11B | 4.08% |
| 2024-12-31 | 16.43B | 4.17% |

**Comprehensive Analysis**

Based on the provided data, Intuitive Surgical (ISRG) has shown a significant increase in its cumulative return, outperforming the S&P 500 (VOO) by 71.80% with a relative divergence of 46.70%. The company's Alpha, Beta analysis indicates strong growth potential, with a Beta of 1.3 or higher in five out of eight periods.

The recent stock price fluctuations show a mild decrease, with the 5-day SMA and 20-day SMA above the current price. The RSI and PPO indicators suggest a buy signal, while the Market Risk Indicator (MRI) indicates a medium risk level.

The recent news and significant events suggest a positive outlook for the company, with FDA clearances and strong earnings beats. The analyst opinions indicate a strong buy consensus, with a target price range of 611.82 to 750.00.

The recent earnings analysis shows a steady increase in EPS and revenue, with a peak in 2025-07-23. The financial information reveals a strong revenue growth and high profit margin, with a peak of 68.04% in 2024-12-31.

Overall, Intuitive Surgical (ISRG) appears to be a solid investment opportunity, with a strong growth potential and a positive outlook. However, as with any investment, it is essential to conduct thorough research and consider multiple factors before making a decision.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.